Teva Pharmaceutical's inaugural R&D Day unveiled three first-in-class drugs targeting Tourette syndrome in children, celiac disease, and IBD - conditions no approved therapy fully addresses - …

Get live updates on this topic:
Silent notifications:
Interval of time threshold:
Get live updates on this topic:
Silent notifications:
Interval of time threshold:
We will only send you breaking news updates, and your own specified custom filters notifications.